These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 19041137)

  • 1. A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis.
    Xi C; Tan L; Sun Y; Liang F; Liu N; Xue H; Luo Y; Yuan F; Sun Y; Xi Y
    Mol Immunol; 2009 Feb; 46(4):729-37. PubMed ID: 19041137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
    Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
    Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
    Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
    Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
    Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chicken type II collagen induced immune tolerance of mesenteric lymph node lymphocytes by enhancing beta2-adrenergic receptor desensitization in rats with collagen-induced arthritis.
    Zhao W; Tong T; Wang L; Li PP; Chang Y; Zhang LL; Wei W
    Int Immunopharmacol; 2011 Jan; 11(1):12-8. PubMed ID: 20955833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
    Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
    Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen.
    Chiocchia G; Boissier MC; Manoury B; Fournier C
    Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of collagen arthritis.
    Brand DD; Kang AH; Rosloniec EF
    Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D; Hill JA; Cairns E; Bell DA
    J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
    Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
    Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.
    Morgan ME; Witteveen HJ; Sutmuller RP; de Vries RR; Toes RE
    Hum Immunol; 2004 Nov; 65(11):1319-27. PubMed ID: 15556682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
    Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
    Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
    Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
    Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
    Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
    Chen J; Zhang XM; Xu Q
    Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
    Chu CQ; Londei M
    J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative modification of type II collagen differentially affects its arthritogenic and tolerogenic capacity in experimental arthritis.
    Marcinkiewicz J; Biedroń R; Maresz K; Kwaśny-Krochin B; Bobek M; Kontny E; Maśliński W; Chain B
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):284-91. PubMed ID: 15467493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.